First Midwest Bank Trust Division’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-1,954
Closed -$246K 385
2021
Q3
$246K Sell
1,954
-9
-0.5% -$1.16K 0.04% 333
2021
Q2
$266K Buy
1,963
+167
+9% +$22K 0.04% 341
2021
Q1
$244K Hold
1,796
0.03% 348
2020
Q4
$253K Buy
+1,796
New +$230K 0.04% 323

Other funds holding XBI

First Midwest Bank Trust Division's XBI Position: Q4 2021 in Review

First Midwest Bank Trust Division sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2021, closing a stake of 1,954 shares — an estimated $246K sold.

First Midwest Bank Trust Division first reported a position in XBI in Q4 2020 and held it in 4 quarters. The position peaked at $266K in Q2 2021. 702 funds tracked by Wall St. Rank hold XBI as of Q4 2021.

  • First Midwest Bank Trust Division reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2021 after selling out during the quarter.
  • First Midwest Bank Trust Division sold 1,954 State Street SPDR S&P Biotech ETF shares in Q4 2021, an estimated $246K.
  • First Midwest Bank Trust Division first reported a position in State Street SPDR S&P Biotech ETF in Q4 2020 and held it in 4 quarters.
  • First Midwest Bank Trust Division's State Street SPDR S&P Biotech ETF position peaked at $266K in Q2 2021.
  • 702 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2021.

Based on First Midwest Bank Trust Division's 13F filing for Q4 2021, filed 18 Jan 2022.